Carta Revisado por pares

Use of global assays to monitor emicizumab prophylactic therapy in patients with haemophilia A with inhibitors

2019; Wiley; Volume: 25; Issue: 2 Linguagem: Inglês

10.1111/hae.13689

ISSN

1365-2516

Autores

Donald F. Brophy, Erika G. Martin, Janice Kuhn,

Tópico(s)

Platelet Disorders and Treatments

Resumo

HaemophiliaVolume 25, Issue 2 p. e121-e123 LETTER TO THE EDITOR Use of global assays to monitor emicizumab prophylactic therapy in patients with haemophilia A with inhibitors Donald F. Brophy, Corresponding Author Donald F. Brophy dbrophy@vcu.edu orcid.org/0000-0003-3447-8523 Coagulation Advancement Laboratory, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University (VCU) School of Pharmacy, Richmond, Virginia Correspondence Donald F. Brophy, Coagulation Advancement Laboratory, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University, Richmond, VA. Email: dbrophy@vcu.eduSearch for more papers by this authorErika J. Martin, Erika J. Martin Coagulation Advancement Laboratory, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University (VCU) School of Pharmacy, Richmond, VirginiaSearch for more papers by this authorJanice Kuhn, Janice Kuhn orcid.org/0000-0002-5067-2943 Division of Hematology/Oncology, VCU School of Medicine, Richmond, VirginiaSearch for more papers by this author Donald F. Brophy, Corresponding Author Donald F. Brophy dbrophy@vcu.edu orcid.org/0000-0003-3447-8523 Coagulation Advancement Laboratory, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University (VCU) School of Pharmacy, Richmond, Virginia Correspondence Donald F. Brophy, Coagulation Advancement Laboratory, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University, Richmond, VA. Email: dbrophy@vcu.eduSearch for more papers by this authorErika J. Martin, Erika J. Martin Coagulation Advancement Laboratory, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University (VCU) School of Pharmacy, Richmond, VirginiaSearch for more papers by this authorJanice Kuhn, Janice Kuhn orcid.org/0000-0002-5067-2943 Division of Hematology/Oncology, VCU School of Medicine, Richmond, VirginiaSearch for more papers by this author First published: 12 February 2019 https://doi.org/10.1111/hae.13689Citations: 10Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume25, Issue2March 2019Pages e121-e123 RelatedInformation

Referência(s)
Altmetric
PlumX